4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-17-065251
10% owner acquired 10,756,249 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ARCH Venture Fund VIII, L.P. 10% owner | 2017-12-12 | Conversion | +10,756,249 | 11,068,749 | D | ||
| Derivatives | |||||||
| ARCH Venture Fund VIII, L.P. 10% owner | 2017-12-12 | Conversion · Series A-1 Preferred Stock | −10,068,749 | 0 | D | ||
| ARCH Venture Fund VIII, L.P. 10% owner | 2017-12-12 | Conversion · Series A-2 Preferred Stock | −375,000 | 0 | D | ||
| ARCH Venture Fund VIII, L.P. 10% owner | 2017-12-12 | Conversion · Series B-1 Preferred Stock | −312,500 | 0 | D | ||
Loading xslF345X03/doc4.xml…